Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DAP000669

Drug Information
NameEtomidate
Synonyms1-(alpha-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester; Prestwick0_001041; 1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, ethyl ester; Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate; Etomidate [USAN:BAN:INN]; Radenarcon; HMS1571A04; C14H16N2O2; CHEBI:129025; R-26490; S1329_Selleck; R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate; UNII-Z22628B598; 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (+-)-; Etomidate (USAN/INN); SBB066197; 1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester; CHEMBL23731; Etomidate; Prestwick1_001041; R 16659; Etomidatum [INN-Latin]; R 26490; HMS1612G10; C07522; Amidate, Etomidate; ethyl 3-(1-phenylethyl)imidazole-4-carboxylate; MolPort-000-917-569; 15301-65-2; HMS2093P17; LS-78232; D-Etomidate; BRN 0665833; D005045; CID36339; (+)-Etomidate; CPD000010931; Hypnomidate; R26490; 3-(1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester; Etomidatum; AC1Q64LP; SPBio_002901; Amidate (pharmaceutical); MLS000034952; Etomidic acid; BAS 01947657; (+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate; (d)-Etomidate; AC1Q34BV; Radenarkon; Ethomidate; Ethnor; D00548; AKOS000548952; MLS001240191; (R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester; Amidate; AC1L1VLF; EINECS 251-385-9; DB00292; Imidazole-5-carboxylic acid, 1-(alpha-methylbenzyl)-, ethyl ester, (R)-(+)-; Etomidato; Amidate (TN); Prestwick2_001041; Etomidato [INN-Spanish]; SAM002548930; Absele; 33125-97-2; 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (R)-; 1-(1-Phenylethyl)-imidazole-5-carboxylic acid, ethyl ester; SMR000010931; 1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (+)-; AC-5898
Trade NameAmidate
CompanyJanssen Pharmaceutica
IndicationAnesthetic
[ICD9: 338   ICD10: R52]
Approved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12
/h4-11H,3H2,1-2H3
InChIKeyNPUKDXXFDDZOKR-UHFFFAOYSA-N
Canonical SMILESCCOC(=O)C1=CN=CN1C(C)C2=CC=CC=C2    
Therapeutic ClassAnalgesics
CAS NumberCAS 33125-97-2
FormulaC14H16N2O2
PubChem Compound IDCID 36339.
PubChem Substance IDSID 9725.
SuperDrug ATC IDN01AX07
SuperDrug CAS ID033125972;
TargetGamma-aminobutyric acid receptor subunit alpha-1Antagonist[2][3]
Ref 1Anaesthetic drugs: linking molecular actions to clinical effects. Curr Pharm Des. 2006;12(28):3665-79. To Reference
Ref 2DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Res. 2008 Jan;36(Database issue):D901-6. Epub 2007 Nov 29. To Reference
Ref 3Glutamate- and GABA-based CNS therapeutics. Curr Opin Pharmacol. 2006 Feb;6(1):7-17. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543